MDD Flashcards
what are some differences between depressive disorders
duration, timing, etiology
T or F: treating parental depression has no effect on psychiatric symptoms in children
F- lowered psyc sx in children
T or F: MDD is the second leading cause of global disabiltiy
T
which of the following does not describe MDD diagnosis
1. you must have 5 symptoms from criteria A
2. patients often present with physical symptoms
3. criteria B states that the sx could not be from something else
4. diagnosis is 5 sx from criteria A, then B + C in addition
3- criteria B = clinically sig distress/ impaired functioning
C = not from substance/ other med condition
what are the 9 criteria from criteria A for MDD? What are the 2 points that the pt must have at least 1 of?
2 points: loss of interest, depressed mood
change in appetite and weight, fatigue, changes in sleep, psychomotor agitation or retardation, slowed thought process, feelings of worthlessness/ guilt, thoughts of suicide/ death
what is considered mild MDD
few if any sx if excess + distressing but manageable and minor fxn impairment
what is considered severe MDD
many sx in excess + seriously distressing and impacting function
how can medical conditions be associated with MDD through physical/ chemical mechs
shared sx
MDD causes bio changes that leads to other sx
other sx has bio effects that promotes MDD
name 3 clinical RF for MDD
Hx/ FamHx of depression
Psychosocial adversity
Higher users of med system
Chronic med conditions (esp CVD, DM, neuro)
Other psych conditions
Times of hormonal challenge (ex- peripartum)
name 3 symptom RF for MDD
Unexplained physical sx
Chronic pain
Fatigue
Insomnia
Anxiety
Substance abuse
Using rating scales can improve outcomes like ________ and _______
sx remission
adherence
what is the 2 question screen
in the last month, have you been bothered by little interest/ pleasure in doing things + have you been feeling down/ depressed/ hopeless → yes to either = further assessment
what are some clinician rated symptom rating scales
HAM-D, MADRS, IDS, GDS
what are some patient rated symptom rating scales
PHQ-9, IDS-SR
onset of MDD
any age, risk increases with puberty, peaks in 20s but late onset is not uncommon
regarding the disease course of MDD
1. most patients are episodically depression and hypomanic
2. most patients feel well between MDEs
3. the duration of episodes increases with age
4. the pattern is more frequent in females
2
Partial remission: sx of prev MDE present but _________(or ____without any sig sx of MDE following end of an episode)
full criteria not met
<2mths
________: no sig sx of MDE in last 2 mths (or 1-2sx to no more than a mild degree)
Full sx remission
Full sx remission: no sig sx of MDE in_______(or ___________ degree)
last 2 mths
1-2sx to no more than a mild
which of the following does not apply to psychotherapy
1. more frequency sessions may have beneficial results, esp in the acute phase
2. less than 2 sessions are not proven to be beneficial
3. psychotherapy + AD is more effective than AD alone
4. 1+2
2
3 NHPs for MDD
st john’s wort
omega 3s
SAM-e
st john’s wort indication in MDD
1st line mono tx for mild-mod MDD
AEs of st john’s wort
serotonin sx
hypomania when combined with ADs- CYP3A4 inducer
st john’s wort is a CYP3A4 ___
inducer
waht is first line for mild MDD
psychoeducation, self management, psyc tx, pharm tx (consider + SDM)
what is first line for mod-severe MDD
2nd gen AD
what are some first line SSRIs
citalo/escitalopram, fluoxetine, fluvoxamine
what are some first line SNRIs
desvenlafaxine, venlafaxine, duloxetine
what is a first line NDRI
bupropion
first line adjunctive drugs to ADs
aripiprazole, quetiapine, risperidone
ketamine is a __________ that _______- pick from the following list
- selective or nonselective
- ______ receptor agonist/ antagonist
- decreases/ increases ___________
nonselective NMDA receptor antagonist
decreases glutamate
what limits the use of NMDA outside of psyc spec
hallucinogenic/ abuse potential
what is considered early improvement from AD
> 20-30% improvement from baseline after 2-4wks at target dose
what is considered a response to AD tx? what about a partial response or a nonresponse?
> 50% improvement in 6-12wks
partial: 25-49%
nonresp: <25%
what is considered a remission from MDE
no sig s/s in the last 2 mths
or based off a predefined cut off
or 1-2 sx that are mild
at 6-12wks
if there is no early improvement, but no AEs at 2-4wks, what should you do?
optimize dose and wait another 2-4wks
if at 2-4wks dose is maxed and there is still no early improvement, ….
switch or adjunct
a patient has had 3 AD trials in the past, doses are maxed, and no early improvement is seen at 4wks. what should you do?
switch to a second line or third line AD
when should you switch ADs?
first AD trial
AEs felt
no response <25% improvement
no time crunch
pt pref to switch